Atomistry » Fluorine » PDB 8pgi-8py3 » 8pqh
Atomistry »
  Fluorine »
    PDB 8pgi-8py3 »
      8pqh »

Fluorine in PDB 8pqh: Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib

Enzymatic activity of Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib

All present enzymatic activity of Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib:
2.7.10.1;

Protein crystallography data

The structure of Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib, PDB code: 8pqh was solved by A.Teuber, S.Kleinboelting, M.P.Mueller, D.Rauh, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 46.57 / 2.50
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 52.27, 73.26, 102.59, 90, 90, 90
R / Rfree (%) 21.8 / 24.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib (pdb code 8pqh). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib, PDB code: 8pqh:

Fluorine binding site 1 out of 1 in 8pqh

Go back to Fluorine Binding Sites List in 8pqh
Fluorine binding site 1 out of 1 in the Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Pdgfra T674I Mutant Kinase Domain in Complex with Avapritinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1001

b:76.9
occ:1.00
F A:9JI1001 0.0 76.9 1.0
C17 A:9JI1001 1.4 76.4 1.0
C16 A:9JI1001 2.3 74.8 1.0
C18 A:9JI1001 2.3 73.6 1.0
CD2 A:LEU629 3.0 81.1 1.0
O A:MET628 3.3 74.0 1.0
C A:MET628 3.6 73.4 1.0
CD1 A:LEU641 3.6 69.4 1.0
C15 A:9JI1001 3.6 74.7 1.0
C19 A:9JI1001 3.6 72.8 1.0
CG A:LEU629 3.7 81.0 1.0
CG A:LYS627 3.9 68.9 1.0
CD2 A:LEU641 3.9 73.9 1.0
N A:MET628 4.0 68.1 1.0
N A:LEU629 4.0 75.6 1.0
CD A:LYS627 4.0 73.7 1.0
C14 A:9JI1001 4.1 74.7 1.0
CA A:MET628 4.2 70.5 1.0
CE A:LYS627 4.2 76.4 1.0
CG A:LEU641 4.2 71.1 1.0
CA A:LEU629 4.3 78.8 1.0
CA A:GLY605 4.6 81.4 1.0
C A:LYS627 4.6 68.5 1.0
CB A:LEU629 4.6 81.0 1.0
CB A:LEU641 4.6 78.7 1.0
N A:LYS606 4.8 77.0 1.0
O A:LYS606 4.8 70.7 1.0
CB A:LYS627 4.9 66.5 1.0
CD1 A:LEU629 4.9 79.1 1.0

Reference:

A.Teuber, T.Schulz, B.S.Fletcher, R.Gontla, T.Muehlenberg, M.-L.Zischinsky, J.Niggenaber, J.Weisner, S.B.Kleinboelting, J.Lategahn, S.Sievers, M.P.Mueller, S.Bauer, D.Rauh. Avapritinib-Based Sar Studies Reveal A Binding Pocket in Kit and Pdgfra Nat Commun 2023.
ISSN: ESSN 2041-1723
DOI: 10.1038/S41467-023-44376-8
Page generated: Fri Aug 2 22:20:51 2024

Last articles

Mg in 4Y52
Mg in 4Y30
Mg in 4Y2V
Mg in 4Y2X
Mg in 4Y2Y
Mg in 4Y2U
Mg in 4Y2T
Mg in 4Y2Q
Mg in 4Y2R
Mg in 4Y2S
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy